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ABSTRACT Neisseria meningitidis and Neisseria gonorrhoeae are pathogenic bacteria
that can cause human infections. While N. meningitidis infections are associated with
bacterial meningitis and bacteremia, a strain of N. meningitidis, isolated from the urogenital system, has recently been associated with urethritis. As this strain is becoming
prominent as an emerging pathogen, it is essential to assess identiﬁcation tools for N.
meningitidis and N. gonorrhoeae urogenital isolates. Consecutive N. meningitidis isolates
recovered from urogenital cultures of symptomatic patients with presumptive diagnoses of gonorrhea and a random selection of N. gonorrhoeae isolates recovered from
the same population within the same time frame were characterized with routine
identiﬁcation systems, antimicrobial susceptibility testing, and whole-genome sequencing. Matrix-assisted laser desorption ionization–time of ﬂight mass spectrometry
(MALDI-TOF MS), multilocus sequence typing, 16S rRNA gene sequence, and average
nucleotide identity methods accurately identiﬁed 95% (18/19) of N. meningitidis and N.
gonorrhoeae isolates. With the Aptima Combo 2 CT/NG test, 30% (3/10) of N. meningitidis isolates were misidentiﬁed as N. gonorrhoeae, but no misidentiﬁcations were found
with the Xpert CT/NG nucleic acid ampliﬁcation test (NAAT). Phylogenetic core genome
and single nucleotide polymorphism (SNP)-based grouping analyses showed that urogenital N. meningitidis isolates were highly related and phylogenetically distinct from N.
gonorrhoeae and respiratory N. meningitidis isolates but similar to urogenital N. meningitidis isolates from patients with urethritis in the United States. Urogenital N. meningitidis
isolates were predominantly azithromycin resistant, while N. gonorrhoeae isolates
were azithromycin susceptible. These data indicate that urogenital isolates of N. meningitidis can cause false-positive detections with N. gonorrhoeae diagnostic assays.
Misidentiﬁcation of urogenital N. meningitidis isolates may confound public healthrelated activities for gonorrhea, and future studies are needed to understand the
impact on clinical outcome of N. meningitidis urogenital infection.
KEYWORDS Neisseria, urethritis, whole-genome sequencing, antibiotic resistance

N

eisseria gonorrhoeae and Neisseria meningitidis are human bacterial pathogens
that can occupy different niches in the body (1, 2). N. gonorrhoeae is the causative
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agent of the sexually transmitted infection gonorrhea, which impacts 78 million people
worldwide (3). As an obligate pathogen, N. gonorrhoeae primarily colonizes the genital
mucosa and has evolved virulence factors that allow it to survive and evade the host
immune system (1). Recently, N. gonorrhoeae has received increased public health
attention, and drug-resistant N. gonorrhoeae has been categorized as an urgent threat
by the U.S. Centers for Disease Control and Prevention due to resistance to commonly
used antibiotics, limiting treatment in patients (4–6). Molecular point-of-care and sample-to-answer assays have been developed to rapidly and accurately identify the presence of N. gonorrhoeae in clinical specimens (7). While the development of these assays
is important for patient treatment, there is evidence for sporadic false-positive molecular results due to cross-reactivity between Neisseria species (8).
N. meningitidis is found as a commensal in the respiratory system, and ;10% of
healthy adults and 40% of men who have sex with men (MSM) demonstrate naso/oropharyngeal carriage (2). N. meningitidis is also a leading cause of bacterial meningitis
and causes signiﬁcant morbidity and mortality in children and young adults, with an
estimated 1.2 million cases of meningococcal infection per year worldwide (9). The virulence of N. meningitidis is determined by host factors (i.e., complement deﬁciency)
and several virulence genes that facilitate adherence and survival in the respiratory system and invasion of the bloodstream (9).
The genus Neisseria has evolved mechanisms that result in a high frequency of horizontal gene transfer (HGT), both within and between species, with up to 10% of the N.
meningitidis genome made up of mobile genetic elements (9, 10). Colocalization of N.
meningitidis and N. gonorrhoeae in the urogenital system may result in increased transfer of virulence or antibiotic resistance genes (11). Recent studies have identiﬁed a
strain of N. meningitidis that has been isolated from the urogenital system and is associated with urethritis (12–16). As this strain becomes a more prominent emerging
pathogen in areas with high N. gonorrhoeae infection rates, it is essential to assess the
ability of identiﬁcation tools to discriminate between N. meningitidis and N. gonorrhoeae urogential isolates (13, 14, 17).
Following the implementation of a total laboratory automation system for culturebased microbiology (BD Kiestra total laboratory automation (TLA) system; Beckton
Dickinson), the clinical microbiology laboratory at Barnes Jewish Hospital in St. Louis,
MO, observed signiﬁcant increases in the recovery of N. gonorrhoeae and, more
recently, N. meningitidis incidentally from urine specimens submitted for routine culture-based testing (18). In this study, we characterize consecutively recovered N. meningitidis and compare them to N. meningitidis urethritis and invasive strains reported
elsewhere.
MATERIALS AND METHODS
Clinical isolates and human study approval. Consecutive Neisseria meningitidis and a random
selection of Neisseria gonorrhoeae isolates recovered from March 2018 to March 2019 from clinical specimens submitted for routine testing to the Barnes Jewish Hospital Clinical Microbiology Laboratory in St.
Louis, MO, were included in this study. Previous studies from our laboratory found increased recovery of
N. gonorrhoeae and N. meningitidis isolates incidentally from urine cultures submitted for routine testing
when incubated with the Kiestra total laboratory automation (TLA) (18). Study isolates were deidentiﬁed,
but patient age, gender, and isolate source were documented. This study was approved by the Human
Research Protection Ofﬁce of Washington University School of Medicine.
Laboratory characterization. Frozen N. meningitidis and N. gonorrhoeae isolates were subcultured
to chocolate (CHC) agar (Hardy Diagnostics, Santa Maria, CA), incubated at 35°C and 5% CO2, and passaged twice prior to additional testing. For phenotypic characterization, 10 m l of a 0.5 McFarland (McF)
suspension of each isolate was cross-struck to CHC and modiﬁed Thayer-Martin (MTM) (Hardy
Diagnostics, Santa Maria, CA) to achieve less subjective interpretation and was quadrant struck to a third
CHC plate with 10 m g colistin disk (BD BBL, Sparks, MD). Following incubation at 35°C and 5% CO2 for 18
to 20 h, CFU were enumerated and the colistin zone size to the nearest millimeter was recorded. For biochemical characterization, the RapidID NH system (Remel, Lenexa, KS) was used per the manufacturer’s
instructions. Brieﬂy, biochemical strips were inoculated with 3 McF suspensions of each isolate and incubated at 35°C for 4 h in air. Following incubation, biochemical reactions were read and scored, and
microcodes were interpreted using the ERIC system to obtain organism identiﬁcations. For molecular
characterization with matrix-assisted-laser desorption ionization–time of ﬂight mass spectrometry
(MALDI-TOF MS), 2 commercially available systems were utilized, Bruker BioTyper (Bruker, Billerica, MA)
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and Vitek MS (bioMérieux, Durham, NC). Brieﬂy, single colonies of pure growth were spotted to target
slides and overlaid with matrix prior to analysis on each instrument per the manufacturer’s instructions.
For N. meningitidis isolates, target slides were spotted with organism and matrix and fully dried inside a
biosafety cabinet (BSC) before removal for loading onto the MALDI-TOF MS instrument. For analysis with
commercial in vitro diagnostic (IVD) nucleic acid ampliﬁcation tests (NAATs), both contrived swab and
urine specimens of N. meningitidis and N. gonorrhoeae isolates were tested to conﬁrm the lack of matrixspeciﬁc effects. Swabs from Aptima vaginal and Xpert vaginal/endocervical specimen collection kits
were inserted into a 0.5-McF suspension of each isolate for 10 s, or 0.5-McF isolate suspensions were
diluted 10-fold with remnant urine specimens previously determined to be negative for Chlamydia trachomatis and Neisseria gonorrhoeae. Both contrived swab and urine specimens were tested with the
Aptima Combo 2 CT/NG (A-CT/NG) on the Tigris GTS system (Hologic, Inc., San Diego, CA) and the Xpert
CT/NG (X-CT/NG) assay on the GeneXpert Inﬁnity system (Cepheid, Sunnyvale, CA) per the manufacturer’s instructions.
Antimicrobial susceptibility testing. Antimicrobial susceptibility testing (AST) of N. meningitidis
and N. gonorrhoeae isolates was performed using disk diffusion and gradient diffusion strips, and the
MIC and/or disk diffusion zone size was interpreted according to the Clinical and Laboratory Standards
Institute (CLSI) M100, 29th edition (19). For N. meningitidis isolates, 0.5 McF suspensions of test isolates
were inoculated to Mueller-Hinton Agar with 5% sheep blood and incubated with penicillin, azithromycin, ceftriaxone ETESTs (bioMérieux, Durham, NC) and ciproﬂoxacin (5 m g), rifampin (5 m g), minocycline
(30 m g) and trimethoprim-sulfamethoxazole disks (1.25/23.75 m g) (BD BBLTM, Sparks, MD) at 35°C and 5%
CO2, for 20–24 h. For N. gonorrhoeae isolates, 0.5-McF suspensions of test isolates were inoculated to GC
agar base with 1% deﬁned growth supplement and incubated with penicillin, azithromycin, ceftriaxone
Etests (bioMérieux, Durham, NC), and ciproﬂoxacin (5 m g) and rifampin (5 m g) disks (BD BBL, Sparks, MD)
at 35°C and 5% CO2, for 20 to 24 h. MIC doubling dilutions and zone sizes to the nearest millimeter were
read with reﬂected light and interpreted per CLSI M100, 29th edition, guidelines (19). AST categorical
results were visualized using pheatmap (R) with color strips used to indicate the source of the isolate,
species, and SNP pairwise distance-based grouping.
Whole-genome sequencing. Total genomic DNA was extracted from cell cultures suspended in
1 ml of deionized water using the QIAamp BiOstic bacteremia DNA kit (Qiagen, Germantown, MD, USA).
We quantiﬁed the DNA concentration using Qubit double-stranded DNA (dsDNA) assays (Thermo Fisher
Scientiﬁc). Illumina sequencing libraries were prepared using 5 ng/m l of isolate DNA in a modiﬁed
Nextera kit protocol (Illumina, San Diego, CA, USA). We then pooled and sequenced libraries on a
NextSeq high-output platform (Illumina) to obtain ;2 million 2  150-bp reads. The reads were demultiplexed by barcode, adapters were removed with Trimmomatic v.36, and contaminating human sequences were removed with Deconseq v.4.3 (20, 21). We assembled processed reads into draft genomes
using the de novo assembler SPAdes v3.11 (22). The quality of draft genomes was assessed using QUAST
v.4.5 and CheckM (23, 24). Assembles were considered to have passed quality control when the assembly length represented in contigs of ,1 kb was less than 10%, the number of contigs greater than
500 bp was less than 5,000, completeness was greater than 90%, and contaminated reads were less than
5%. Draft genomes were annotated using Prokka v.1.12 (25).
Genomic taxonomic identiﬁcation. Following draft genome assembly, we determined genomic
taxonomic identiﬁcation by average nucleotide identity (ANI), 16S rRNA gene identiﬁcation, and multilocus sequence typing (MLST). The assembled scaffolds were submitted to the Neisseria multilocus
sequence typing website (https://pubmlst.org/neisseria/) to determine MLST and clonal complex (26).
For all isolates, 16S rRNA gene sequences were identiﬁed using RNAmmer v.1.2 and submitted to the EZ
BIoCloud taxonomic database for classiﬁcation (27, 28). Using ANI analysis, species were determined if
the genome in question had .95% ANI with the type genome (N. meningitidis, NM_MC58; N. gonorrhoeae, NG_ref_FA_1090) using dnadiff (29). Pairwise ANI for each isolate was clustered and visualized
using pheatmap (R) (30).
Phylogenetic analysis. To phylogenetically compare isolate sequences, 16S rRNA gene sequences
identiﬁed by RNAammer were aligned using MUSCLE, and an approximate maximum likelihood tree
was built with FastTree (31, 32). FastTree uses a heuristic variant of neighbor joining to construct a rough
topology, reduces the length of the tree using a mix of nearest-neighbor interchanges and subtreeprune-regraft moves, and improves the tree with maximum-likelihood rearrangements (32). Branch
length precision was rounded to 0.0001 substitutions per site. The output Newick ﬁles were visualized
and annotated with isolate source using ggtree (R) (33, 34). To compare isolate genomes, .gff ﬁles produced by Prokka were used to construct a core genome alignment with Roary v.3.8.0 for N. meningitidis
(35). Roary alignments were used to create an approximate maximum likelihood tree with FastTree (32).
The output Newick ﬁles were visualized and annotated with isolate source using ggtree (R) (33, 34).
Isolate groupings based on SNP pairwise distances. Snippy v.4.3.8 was used to map forward and
reserve reads for N. meningitidis isolates to the N. meningitidis MC58 type strain complete genome assembly (ID) and to call SNPs (36). To determine groupings, we compared pairwise SNP distances
between each N. meningitidis isolate pair. Isolates were grouped into perfectly reciprocal groups at every
pairwise distance cutoff between N. meningitidis isolates using igraph v.1.2.4.1 as described previously
(37). Groupings were visualized with a SNP cutoff of 2,000.
Antibiotic resistance mutation identiﬁcation and analysis. Targeted analysis of acquired antibiotic resistance genes/mutations (ARGs) against b -lactams (blaTEM, penA, porA, ponA, mtrR), macrolides/
lincosamides/streptogramins (23S rRNA, mtrR), and quinolones (gyrA, parC) was performed as a result of
phenotypic AST ﬁndings using PointFinder (38). The presence/absence matrix of ARGs was visualized in
pheatmap (R). Associated metadata were displayed as a color strip to represent bacterial isolate
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TABLE 1 Neisseria meningitidis and Neisseria gonorrhoeae isolate characterizationa
Results from:

Age (yrs),
gender
43, M
31, M
27, M
18, F
31, M
43, M
23, M
22, M
29, M
46, M
8, F
21, F
71, M
32, M

35, M
34, M
31, M
29, M
23, M

Source
Urine
Urine
Urine
Urine
Urine
Urine
Urine
Urine
Urine
Respiratory, Sp
Respiratory, TA
Respiratory, BAL
Respiratory, BW
Genital
NA

Serogroupb
Nongroupable
ND
Nongroupable
ND
W135
Nongroupable
Nongroupable
Nongroupable
ND
Nongroupable
NA
Nongroupable
B
Nongroupable
ND

Urine
Urine
Urine
Urine
Urine

ND
ND
ND
ND
ND

R, 6
R, 6
R6
R, 6
R, 6

RapID
NH
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Mo
Nm
Nm
Ng
Nm
Mo
Nm
Ng

VITEK
MS
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm/Np
Nm
Nm
Nm
Ng

Bruker
Biotyper
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Ng

Aptima
CT/NG
Neg
Neg
Ng Posc
Neg
Neg
Ng Posc
Ng Posc
Negc
Neg
Neg
Negc
Neg
Negc
Neg
Ng Pos

Xpert
CT/NG
Neg
Neg
Negc
Neg
Neg
Negc
Negc
Negc
Neg
Neg
Negc
Neg
Negc
Neg
Ng Pos

16S
rRNA ID
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Nm
Np
Nm
Nm
Nm
Ng

MLST
CC
ST-11
No type
ST-11
ST-11
ST-11
ST-11
ST-11
ST-32
ST-11
No type
No type
ST-11
ST-11
ST-4821
No type

Ng
Ng
Ng
Ng
Ng

Ng
Ng
Ng
Ng
Ng

Ng
Ng
Ng
Ng
Ng

Ng Pos
Ng Pos
Ng Pos
Ng Pos
Ng Pos

Ng Pos
Ng Pos
Ng Pos
Ng Pos
Ng Pos

Ng
Ng
Ng
Ng
Ng

No type
No type
No type
No type
No type

aAbbreviations:

M, male; F, female; Sp, sputum; TA, tracheal aspirate; BAL, bronchoalveolar lavage; BW, bronchial wash; Nm, Neisseria meningitis; Ng, Neisseria gonorrhoeae;
Np, Neisseria polysaccharea; Mo, Moraxella osloensis; ND, not done; NA, not applicable; R, resistant; S, susceptible; Pos, positive; Neg, negative for all targets.
bSerogroup determination or conﬁrmatory testing performed by Missouri State Public health Laboratory (MSPHL) Jefferson City, MO.
cConﬁrmed by repeat testing in remnant urine matrix.

identiﬁcation and Aptima CT results. We further validated PointFinder results for key resistance gene
mutations using BLASTn with MUSCLE alignment and maximum likelihood tree visualization (see Fig. S3
in the supplemental material).
Data availability. All assemblies are uploaded to the NCBI under BioProject PRJNA643774.

RESULTS
N. meningitidis urinary isolates can cause false-positive N. gonorrhoeae
molecular test result. Consecutive N. meningitidis isolates and a random selection of
N. gonorrhoeae isolates recovered from clinical specimens during the same time period
were characterized by phenotypic and molecular methods routinely used to identify
Neisseria species in clinical microbiology laboratories, including MALDI-TOF MS and
commercial biochemical and molecular tests. Detailed demographic information was
not available for these isolates, but limited information including patient age and gender, and isolate source is summarized in Table 1. All urogenital N. meningitidis and N.
gonorrhoeae isolates were correctly identiﬁed using the Bruker Biotyper and Vitek MS
MALDI-TOF MS platforms (Table 1). One Neisseria isolate from a respiratory source
(NM12) was incorrectly identiﬁed using MALDI-TOF MS and biochemical tests as N.
meningitidis (Bruker Biotyper) or Neisseria polysaccharea/N. meningitidis (Vitek MS) and
N. gonorrhoeae (RapidID NH). However, this isolate was phenotypically consistent with
nonpathogenic Neisseria species with no growth on MTM medium and a zone of inhibition when incubated with a 10-m g colistin disk on solid medium and was identiﬁed
using whole-genome sequencing (WGS) methods as N. polysaccharea.
Organism suspensions of each isolate were also tested with the Aptima CT/NG
Combo 2 assay (A-CT/NG) on the Tigris DTS system and Xpert CT/NG (X-CT/NG) on the
GeneXpert system. All N. gonorrhoeae isolates were detected by both systems, while all
N. meningitidis isolates were not detected by X-CT/NG. Importantly, urinary isolates of
N. meningitidis (NM04, NM07, NM08) tested positive for N. gonorrhoeae with A-CT/NG.
February 2021 Volume 59 Issue 2 e01699-20
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Isolate
NM02
NM03
NM04
NM05
NM06
NM07
NM08
NM09
NM10
NM11
NM12
NM13
NM14
NM15
NG ATCC
49226
NG01
NG02
NG03
NG04
NG05

Colistin
(10 mg)
disk, zone
size (mm)
R, 6
R, 6
R, 6
R, 6
R, 6
R, 6
R, 6
R, 6
R, 6
R, 6
S, 20
R, 6
R, 6
R, 6
R, 6
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This result was conﬁrmed with remnant urine specimens spiked with NM04, NM07,
NM08, NM09, NM12, and NM14 (Table 1).
Urogenital N. meningitidis classiﬁed as N. meningitidis by MLST, 16S rRNA gene
classiﬁcation, and average nucleotide identity. We performed Illumina whole-genome sequencing (WGS) on all Saint Louis, MO (STL)-collected isolates. After draft genome assembly, scaffolds were submitted to the Neisseria MLST website (https://
pubmlst.org/neisseria/) to determine MLST and clonal complex (26). For 18 of 19
Neisseria isolates, MLST species classiﬁcation agreed with MALDI-TOF MS classiﬁcation.
One respiratory isolate (NM12), which MALDI-TOF MS was unable to classify to a single
species, was characterized as N. polysaccharea. MLST clonal complex indicated that 7
of 10 STL-collected urogenital N. meningitidis isolates fell into the sequence type 11
(ST-11) clonal complex (Table 1).
To determine the phylogenetic context of isolates, we downloaded the following
series of N. meningitidis genomes from NCBI and PubMLST: 28 N. meningitidis isolates
from urinary tract infections (UTIs) in the United States (13, 14), 3 N. meningitidis ST-11
isolates from cases of meningitis in MSM in the United States (39), 29 N. meningitidis
ST-11 isolates from a meningitis epidemic in Africa (40), and 8 N. meningitidis isolates
from non-ST-11 meningitis cases (Table S1).
Ribosomal RNA (rRNA) classiﬁcation is used in the Aptima Combo 2 assay, with the
speciﬁc loci being proprietary (41), and in 16S rRNA gene sequence classiﬁcation to
determine the bacterial operational taxonomic unit (OTU) or amplicon sequence variant (ASV) (28). Thus, we classiﬁed and compared 16S rRNA gene sequences across
Neisseria isolates. For all STL-collected isolates, 16S rRNA gene sequences were submitted to the EZ BIoCloud taxonomic database for classiﬁcation (28). 16S rRNA gene classiﬁcation correlated with MLST for all isolates (Table 1). An approximate maximum likelihood tree with NM12 as the outgroup shows N. gonorrhoeae sequences form a
monophyletic clade distinct from N. meningitidis sequences with N. meningitidis that
tested positive for N. gonorrhoeae using the A-CT/NG falling within the N. meningitidis
sequences (Fig. S1).
Finally, we used ANI for genomic species classiﬁcation. Species were determined if
the genome in question had .95% pairwise ANI with the type genome (Fig. 1). All N.
meningitidis or N. gonorrhoeae isolates from urogenital samples that were identiﬁed by
MALDI-TOF MS and MLST were also identiﬁed as N. meningitidis or N. gonorrhoeae,
respectively, by ANI. NM12 did not fall above the cutoff for N. meningitidis, N. gonorrhoeae, or N. polysaccharea type strains. Pairwise ANI of all N. meningitidis isolates and
select reference N. meningitidis genomes indicated that ST-11 isolates form a distinct
cluster with ANI above 99% (Fig. 1). This cluster included all urogenital N. meningitidis
isolates for which N. gonorrhoeae was detected by A-CT/NG and one N. meningitidis respiratory isolate, NM13. Thus, MALDI-TOF MS, MLST, 16S rRNA, and ANI agree on classiﬁcation for 18 of 19 Neisseria isolates.
N. meningitidis urogenital isolates form a primary lineage that is distinct from
ST-11 meningitis isolates. To determine genomic similarity across N. meningitidis
genomes, we used a core genome alignment of 1,057 genes at 95% identity of all N.
meningitidis isolates, using NM12 as an outgroup. The phylogenetic tree of this alignment shows that urogenital N. meningitidis isolates primarily fall within a single lineage
(Fig. 2). All (3 of 3) STL-collected N. meningitidis isolates for which the A-CT/NG test
detected N. gonorrhoeae formed a single clade within STL-collected ST-11 urogenital N.
meningitidis isolates, suggesting a recent common ancestor. Of the STL-collected urogenital N. meningitidis isolates, 8/10 cluster together and form a sister clade to other
urogenital N. meningitidis isolates. This similarity suggests a single common ancestor
for 93% (31 of 33) of urogenital N. meningitidis isolates. Two urogenital STL-collected N.
meningitidis isolates, NM09 and NM15, did not cluster with other urogenital isolates,
and NM09 was, instead, highly related to a respiratory N. meningitidis isolate. Both
NM09 and NM15 isolates were nongroupable using serotyping methods, did not fall
into the ST-11 clonal complex, and were misclassiﬁed by RapID NH-; NM15 had been
misclassiﬁed as N. gonorrhoeae and NM09 was misclassiﬁed as Moraxella osloensis
jcm.asm.org 5

Sukhum et al.

Journal of Clinical Microbiology

(Table 1). ST-11 urethritis isolates were a sister clade to a lineage that included one
STL-collected respiratory isolate and all 3 of the MSM meningitis isolates. This clade
was a sister clade to the African ST-11 meningitis isolates. In contrast to N. meningitidis
urinary isolates, N. meningitidis respiratory isolates were highly diverse and distantly
related.
N. meningitidis urinary isolates are highly related to other urogenital isolates
and not respiratory isolates. SNP distances across whole genomes have been found
to provide higher resolution of phylogenetic distances than core genome comparisons
(37). Thus, to further investigate the genomic similarity of STL-collected N. meningitidis
isolates, we calculated pairwise SNP distances by mapping quality-ﬁltered reads from
N. meningitidis isolates to the N. meningitidis type strain. To ﬁnd groupings, we used a
grouping technique, “clique” (37), on STL-collected N. meningitidis isolates. We compared pairwise SNP distances between N. meningitidis isolate pairs and iterated
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FIG 1 Identiﬁcation of clinical N. meningitidis (Nm) and N. gonorrhoeae (Ng) by ANI analysis. All N. meningitidis and N. gonorrhoeae isolates from urogenital
samples in St. Louis (STL) were characterized by pairwise ANI with all other isolates from STL and a subset of meningitis and ST-11 meningitis genomes.
Isolates cluster within 96% ANI for all but one N. gonorrhoeae and N. meningitidis isolate. A single isolate (NM12) from a respiratory sample did not fall
above a 96% cutoff for either N. meningitidis or N. gonorrhoeae type strain. Color strips indicate source of isolate, clonal complex identiﬁed my PubMLST,
and Aptima test results.
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FIG 2 Urogenital N. meningitidis isolates primarily fall within a single, highly related clade. An approximate maximum
likelihood tree of core genome alignment of St. Louis and select Neisseria isolates with tree branch lengths of .0.0001 is
shown. Two urogenital isolates collected from St. Louis fall outside of this clade and are distantly related to the ST-11 clonal
complex. All isolates that tested positive for N. gonorrhoeae fall into a clade with other urogenital N. meningitidis isolates. The
source is indicated by color of the tip, and Aptima test results are indicated by the shape of tip. Ng, N. gonorrhoeae.
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FIG 3 Urogenital N. meningitidis isolates primarily form a single SNP pairwise distance-based
grouping. (A) Histogram of pairwise SNP distances indicates three modes of pairwise distances. The
ﬁrst corresponds to within clade, the second to within species, and the third to between species. We
deﬁne variant threshold as variant pairwise distances that fall before 2,000 (black line). (B) Groupings
are visualized on the N. meningitidis core genome phylogeny. Group 1 includes 8 of 10 urogenital
isolates. Group 2 includes a respiratory and a urogenital isolate. The source is indicated by color of
the tip, and Aptima test results are indicated by the shape of the tip. Ng, N. gonorrhoeae.

through each unique SNP distance cutoff to ﬁlter the isolate pairwise network list (Fig.
3A). For each cutoff, we found reciprocal groups and recorded the number of groups
and isolates per group. Then, groups were deﬁned as complete subgraphs, where each
node in the group was connected to every other node in the group. The number of N.
meningitidis groups rose initially from 1 to 3 groups as SNP distances increased from
357 to 6,269. Only a single SNP distance of 5,624 SNPs had 4 groups, and immediately
after this peak, groups decreased again to 3, with a decline in group size to 1 after
February 2021 Volume 59 Issue 2 e01699-20
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20,000 SNPs. Figure 3A shows the groups, which correspond to a SNP cutoff that
includes only highly related N. meningitidis isolates with less than 2,000 SNP distances.
Urogenital N. meningitidis isolates primarily formed a single grouping (Fig. 3B). The
ﬁrst grouping includes 8/10 urogenital isolates and all ST-11 urethritis isolates. This
grouping fell entirely with the ST-11 urogenital clade described in the core genome
phylogeny (Fig. 2). A second grouping included a respiratory (NM11) and a urogenital
(NM09) isolate. These groupings suggest that while ST-11 urethritis isolates are highly
related with between 9.5 and 9.6  1024 pairwise SNPs/genome length, not all urogenital isolates fall into the grouping, and one isolate shares high similarity (4.8  1024
pairwise SNPs/genome length) with a respiratory isolate.
N. meningitidis isolates have an antibiotic susceptibility proﬁle distinct from N.
gonorrhoeae isolates. To consider clinical implications of misidentiﬁed N. meningitidis
isolates, we performed phenotypic AST on all STL-collected isolates. AST was performed against azithromycin, penicillin, ceftriaxone, rifampin, ciproﬂoxacin, minocycline, trimethoprim-sulfamethoxazole, and colistin. AST proﬁles varied between
N. gonorrhoeae isolates and urogenital N. meningitidis isolates (Fig. 4A). Most N.
meningitidis isolates tested nonsusceptible to azithromycin with MIC50/90 of 4 m g/ml
(range, 0.5 to 4 m g/ml) compared to N. gonorrhoeae isolates, which were mostly susceptible to azithromycin with MIC50 of 0.125 m g/ml and MIC90 of 2 m g/ml (range,
0.064 to 2 m g/ml). The respiratory isolate, NM012, has a unique AST proﬁle distinct
from both N. gonorrhoeae and N. meningitidis isolates in that it tested resistant to
azithromycin, penicillin, ciproﬂoxacin, and trimethoprim-sulfamethoxazole. We also
evaluated chromosomal point mutations that may account for antibiotic resistance
in Neisseria both by using PointFinder and by individually validating mutations of
known interest in speciﬁc genes (Table S2, Fig. S3). Point mutations for resistance
were primarily shared by species (Fig. S2). One prominent point mutation in N. meningitidis isolates was in nonmosaic penA allele p.N512Y. This point mutation is associated with mosaic penA, which can contribute to decreased susceptibility to
expanded-spectrum cephalosporins (42); however, all isolates in this study were
ceftriaxone susceptible with MIC of #0.016 m g/ml. While all urogenital N. meningitidis isolates and 1/3 respiratory N. meningitidis isolates had this mutation, this mutation was not present in any N. gonorrhoeae isolate. Isolates within the same SNP
pairwise distance-based grouping had identical resistance mutation proﬁles (Fig. S2
and S3, Table S2).
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FIG 4 The antibiotic susceptibility proﬁle varies between N. gonorrhoeae isolates and urogenital N. meningitidis isolates. (A) The heatmap of AST proﬁles for
each isolate shows N. meningitidis and N. gonorrhoeae isolates organized by 16S phylogenetic gene tree, with major differences being that N. meningitidis
isolates are resistant to azithromycin and intermediate to penicillin, while N. gonorrhoeae isolates are largely susceptible to both antibiotics. Isolate NM12 has
a distinct antibiotic susceptibility proﬁle that varies from both N. gonorrhoeae and N. meningitidis isolates. Color strips indicate the source of isolate, species
identiﬁcation by ANI, and SNP pairwise distance-based grouping. (B) Distributions of MIC and zone diameter for N. meningitidis urogenital isolates and N.
gonorrhoeae respiratory isolates for azithromycin, rifampin, ciproﬂoxacin, and trimethoprim-sulfamethoxazole. Ng, N. gonorrhoeae; Nm, N. meningitidis.
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DISCUSSION
As N. meningitidis becomes an increasingly recognized pathogen in the urogenital
system, accurate species identiﬁcation of N. meningitidis and N. gonorrhoeae urogenital
isolates may be important for clinical care. Thus, it is essential to assess tools used for
identiﬁcation and compare N. meningitidis and N. gonorrhoeae urogenital isolates. In
this study, we demonstrate that 30% (3/10) of urogenital N. meningitidis isolates were
misidentiﬁed as N. gonorrhoeae with the A-CT/NG NAAT and that these urogenital N.
meningitidis isolates were predominantly nonsusceptible to azithromycin. We found
that speciﬁc identiﬁcation using MALDI-TOF MS, MLST, 16S rRNA gene sequence, and
ANI methods was 100% accurate for both urogenital N. meningitidis and N. gonorrhoeae isolates. However, our data indicate that some urogenital isolates of N. meningitidis can cause false-positive detections with N. gonorrhoeae-speciﬁc molecular tests
and that some commensal Neisseria strains can be identiﬁed as N. meningitidis by
MALDI-TOF MS.
While NAAT tests such as the Aptima CT/NG Combo 2 or the Xpert CT/NG are the
standard of care for detection of N. gonorrhoeae from urine and genital specimens in
clinical laboratories, there is evidence that other Neisseria species can cause false-positive N. gonorrhoeae detections (7, 8). A previous report suggested these false-positive
results were sporadic and low level, as no isolate tested positive twice in their study
(8). In contrast, our ﬁndings were not sporadic, as 3 unique urogenital N. meningitidis
isolates were detected as N. gonorrhoeae both when tested as pure isolate suspensions
in saline and when spiked into urine. The Xpert CT/NG NAAT has two N. gonorrhoeaespeciﬁc targets, both of which must be detected to return an N. gonorrhoeae-positive
result, while the Aptima CT/NG Combo 2 NAAT targets a region of the 16S rRNA to
detect N. gonorrhoeae. Since the exact locus of both the Aptima CT/NG Combo 2 and
the Xpert CT/NG tests are proprietary, we are unable to directly test for sequence differences that may result in misidentiﬁcations. However, genomic characterization of
these isolates demonstrated that N. meningitidis isolates that test falsely positive for N.
gonorrhoeae form a distinct clade based on a core genome phylogeny, suggesting a
common ancestor and indicating a genomic component rather than random chance
or a sporadic error in the NAAT test is responsible for the false-positive N. gonorrhoeae
result.
Accurate identiﬁcation of Neisseria isolates is important, as AST proﬁles vary
between N. gonorrhoeae and N. meningitidis isolates. Though rising rates of reduced
susceptibly to azithromycin in N. gonorrhoeae have been reported across the United
States (43), we found that the N. gonorrhoeae isolates tested in our study were primarily susceptible to azithromycin (n = 4/5), while urogenital N. meningitidis isolates collected over the same time period as N. gonorrhoeae isolates were more likely to be
azithromycin nonsusceptible (n = 7/10). Our observation of largely azithromycin-susceptible N. gonorrhoeae is consistent with a previous study of a larger cohort of N. gonorrhoeae isolates recovered from the same institution that reported that azithromycin
nonsusceptibility was rare (,2%) (44). Interestingly, all N. meningitidis isolates that
tested falsely positive for N. gonorrhoeae were azithromycin nonsusceptible (n = 3/3).
Currently, a single dose of intramuscular ceftriaxone (250 mg) plus a single dose of oral
azithromycin (1 g) is the primary treatment recommendation for uncomplicated gonococcal infection (45). Although dual therapy was primarily aimed at treatment of
uncomplicated chlamydial coinfections, routine combination therapy may hinder development of antimicrobial resistance in N. gonorrhoeae, particularly in light of
increased cephalosporin resistance in the United States (43). Given the rare reports of
ceftriaxone-resistant N. meningitidis (46–48), ceftriaxone plus azithromycin dual therapy is likely effective for treatment of urogenital N. meningitidis infection. However,
if azithromycin nonsusceptibility is common among urogenital N. meningitidis isolates
and in the setting of reduced susceptibility to 3rd-generation cephalosporins, current
gonococcal treatment guidelines may be suboptimal for urogenital N. meningitidis
infection. Interestingly, despite recent reports of ciproﬂoxacin-resistant, beta-lactamasejcm.asm.org
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producing N. meningitidis serogroup Y (49), all of the N. meningitidis isolates evaluated in
this study were ciproﬂoxacin and ceftriaxone susceptible (n = 13/13), though most were
nonsusceptible to penicillin (n = 10/13); beta-lactamase testing was not performed.
One hypothesis for conﬂicting identiﬁcation of N. meningitidis isolates may be
increased HGT between N. gonorrhoeae and N. meningitidis. However, our 16S rRNA
gene sequence, MLST, and whole-genome analyses indicate that urogenital N. meningitidis isolates are not more similar to N. gonorrhoeae than other N. meningitidis isolates.
The majority of urogenital isolates for which we performed genomic analyses (n = 35/
37) share a recent common ancestor. This suggests that most cases of N. meningitidis
urethritis are due to the spread of urethritis-associated N. meningitidis ST-11 and not
due to translocation and subsequent infection of respiratory or meningitis-associated
N. meningitidis isolates to the genitourinary tract, consistent with previous reports (11,
15). However, we did observe two instances where urogenital N. meningitidis isolates
were not from the ST-11 urethritis clade, and in one case, a respiratory N. meningitidis
isolate was highly related to a urinary N. meningitidis isolate. This suggests urogenital
N. meningitidis isolates do not derive exclusively from the ST-11 urethritis clade and
that transmission between body sites may be possible.
Studies have indicated that invasive N. meningitidis isolates from MSM are associated with colonization of the urethra or rectum (2) and that N. meningitidis urethritis
outbreaks are closely related to cases of invasive N. meningitidis in MSM populations,
suggesting that urethral colonization may contribute to invasive disease (11). In our
study, the sister clade to all ST-11 urethritis isolates included one respiratory isolate
and three meningitis-associated isolates from MSM patients. This phylogeny suggests
a common ancestor between MSM meningitidis and the origin of urogenital N. meningitidis isolates. However, as this study is focused on urogenital N. meningitidis isolates,
only a subset of 54 N. meningitidis meningitis isolates was used for comparison, with a
focus on N. meningitidis isolates within ST-11. A more exhaustive study of N. meningitidis meningitis isolates may ﬁnd additional clades related to the urogenital NM isolates.
Further, in this data set, we do not see evidence for closely related urethritis and invasive N. meningitidis isolates. It is possible that increasing the collection and analysis of
invasive and urogenital N. meningitidis isolates from meningitis patients may expand
further on this issue.
Public health-related activities associated with gonococcal infection, such as contact-tracing and expedited partner therapy, may be indicated and initiated following
notiﬁcation of this reportable infection. However, misidentiﬁcation of N. meningitidis
can confound these activities, particularly if identiﬁcation of N. gonorrhoeae and/or N.
meningitidis is inconsistent across currently available diagnostic tests. Increased vigilance surrounding these (mis)identiﬁcations will be required for a more complete
understanding of the scope, epidemiology, susceptibility, and clinical outcomes associated with N. meningitidis urogenital infections, as has been previously suggested
(50).
Overall, our ﬁndings demonstrate that some urogenital N. meningitidis isolates are
incorrectly identiﬁed as N. gonorrhoeae by the Aptima CT/NG NAAT despite being correctly identiﬁed as N. meningitidis by other molecular methods, including MALDI-TOF
MS, MLST, 16S rRNA gene sequencing, and ANI analysis. Further, these urogenital N.
meningitidis isolates are related to the ST-11 urethritis-associated N. meningitidis isolates from across the United States. These isolates may be recovered from routine urine
cultures with increasing frequency, as laboratories transition to automated inoculation
and incubation systems. Finally, our studies have found that accurate identiﬁcation of
N. meningitidis and N. gonorrhoeae may be important due to implications for publichealth related activities and potential differences in susceptibility proﬁles. Future studies further describing the scope, epidemiology, clinical course, and outcomes of N.
meningitidis-mediated urogenital infection compared to gonococcal infection will be
needed to justify strategies to identify and/or differentiate N. meningitidis from N. gonorrhoeae urogenital specimens.
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